glp 1 blindness A nurse lost her eyesight while on GLP-1 drugs. She said she did not know of the potential risk, which is listed on the packaging in Europe but not in the U.S blindness with glp 1 NAION

An examination of the ratios of plasma to brain total acylcarnitine levels showed a significant decrease in this ratio in E4 mice after challenge with L-carnitine but not in E3 mice, while there was a trend in E2 mice (Figure 9C)

The clinical characteristics of melanotic macules observed in the present case report were consistent with existing literature, with a notable higher prevalence in women, typically in their fourth to fifth decade of life

M.GrakouiA.HandyJ.SaxenaN

5 Data represented as event rates over a median follow-up of 28 months

Reye's syndrome should be considered in all pediatric cases of MIC-S treated with ASA